Published Feb 18, 2021

Daphne Koller — Digital Biology and the Next Epoch of Science

Join Daphne Koller as she delves into her journey from founding Coursera to pioneering advancements in digital biology, exploring how machine learning is reshaping drug discovery and education through innovative platforms like Engageli, while addressing the challenges and transformative potential of AI in science.
Episode Highlights
Gradient Dissent - A Machine Learning Podcast logo

Popular Clips

Episode Highlights

  • ML Evolution

    The evolution of data and machine learning has significantly transformed various fields, including biology. highlights the progress from 2004 to 2018, where machine learning models have surpassed human capabilities in tasks like image recognition 1. She attributes this to better models, larger datasets, and advanced computing power. The availability of comprehensive datasets, such as the UK Biobank, has been transformative in understanding human biology and developing new methodologies 2. notes, "The combination of better software, better tooling, and better cloud computing has been as transformative as anything else."

       

    Transfer Learning

    Transfer learning is becoming increasingly relevant in machine learning, with applications extending across various domains. explains how models trained on web images can be transferred to microscopy images, showcasing the adaptability of these models 3. This adaptability is crucial for advancing fields like drug discovery, where data scarcity is a challenge. emphasizes the need for large datasets to enable machine learning to break through performance ceilings, as demonstrated by DeepMind's AlphaFold in protein folding 4. She states, "We need to be really thinking hard about how to generate enough data at scale for biological or chemical problems."

       

    Protein Folding

    Breakthroughs in protein folding illustrate the potential of machine learning in biology. discusses how DeepMind's AlphaFold achieved a significant milestone by not relying on preconceptions about physics and chemistry, but instead using vast amounts of data 5. This approach allowed AlphaFold to solve complex problems that traditional methods could not. points out that while protein folding is not the core issue in drug discovery, it exemplifies how machine learning can tackle challenging problems 4. "Machine learning came in and with the right type of model and the right type of data, was really able to crack that nut open," she remarks.

Related Episodes